Abstract:
The present invention provides processes for preparing freeze-dried platelets, freeze-dried platelets made by those processes, platelets reconstituted from those freeze-dried platelets, methods of using the platelets for therapeutic, diagnostic, and research purposes, and kits comprising the freeze-dried platelets.
Abstract:
The present invention provides processes for preparing freeze-dried platelets, freeze-dried platelets made by those processes, platelets reconstituted from those freeze-dried platelets, methods of using the platelets for therapeutic, diagnostic, and research purposes, and kits comprising the freeze-dried platelets.
Abstract:
The present invention pertains to stabilized Αβ oligomer compositions. Methods for generating stabilized Αβ oligomer compounds are also provided herein. Additionally, screening assays employing the Αβ oligomer compounds and methods for generating therapeutics with the Αβ oligomers are also provided. In a particular embodiment, the Αβ oligomer described herein is comprised of Αβ42 peptide.